Caspofungin Acetate (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Caspofungin Acetate drug offered from Fresenius Kabi USA, LLC. This Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: Caspofungin Acetate
SUBSTANCE NAME: CASPOFUNGIN ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-12-30
END MARKETING DATE: 0000-00-00


Caspofungin Acetate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCaspofungin Acetate from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/mL)
START MARKETING DATE: 2016-12-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-356_6ae7b3a8-3fa7-4e05-ae2f-ea64a40e7c34
PRODUCT NDC: 63323-356
APPLICATION NUMBER: NDA206110

Other CASPOFUNGIN ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Athenex Pharmaceutical Division, LLC.Caspofungin Acetate
Fresenius Kabi USA, LLCCaspofungin Acetate
Gland Pharma LimitedCaspofungin Acetate
Merck Sharp & Dohme Corp.CANCIDAS
Mylan Institutional LLCCaspofungin acetate